Status:

COMPLETED

Intermittent Hypoxia Therapy in Cardiac Rehabilitation

Lead Sponsor:

Istituti Clinici Scientifici Maugeri SpA

Conditions:

Cardiovascular Disease

Exercise

Eligibility:

All Genders

75+ years

Phase:

NA

Brief Summary

This is a randomized control pilot study to assess the effect of intermittent hypoxia therapy on functional capacity vs conventional care in old patients with functional impairment admitted to a Phase...

Detailed Description

Because the improvement of exercise tolerance reduces mortality in elderly patients affected by cardiovascular disease, intermittent hypoxia therapy (IHT) - defined as repeated episodes of hypoxia int...

Eligibility Criteria

Inclusion

  • Admission to a Phase 2 in-hospital cardiac rehabilitation program because of a recent index event;
  • Provision of signed and dated informed consent form;
  • Age ≥ 75 years;
  • Basic venous blood oxygen saturation (SpO2) level \> 93% measured at the fingertip;
  • SPPB score \< 7;
  • New York Heart Association (NYHA) Class I-III.

Exclusion

  • Inability to give informed consent (diminished understanding or comprehension);
  • Age \< 75 years;
  • SPPB Score ≥ 7;
  • NYHA Class IV and/or concomitant i.v. therapy with cardiovascular active drugs;
  • Uncontrolled angina pectoris;
  • Uncontrolled arterial hypertension;
  • Uncontrolled atrial or ventricular arrhythmias;
  • Active pericarditis or myocarditis;
  • Need of continuous or intermittent O2 therapy;
  • Hb \< 10 g/dl;
  • Severe concomitant non-cardiac diseases such as cancer or any other systemic disease limiting to participate in the study
  • Acute inflammatory diseases;
  • Acute non-cardiac somatic diseases, or somatic diseases with symptoms of decompensation;
  • Currently implanted left ventricular assist device;
  • Inability to accept the procedure of breathing via facial mask.

Key Trial Info

Start Date :

February 12 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04034082

Start Date

February 12 2019

End Date

October 30 2020

Last Update

December 15 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istituti Clinici Scientifici Maugeri IRCCS

Pavia, Italy, 27100